Plan Amendment

A Plan Amendment, in the context of an employer-sponsored 401(k) retirement plan, refers to any modification or change made to the plan's provisions or features. These amendments can be made by the plan sponsor, which is typically the employer, and are governed by the regulations set forth by the Employee Retirement Income Security Act (ERISA) and the Internal Revenue Service (IRS). The primary purpose of a plan amendment is to enhance or adjust the retirement plan's terms, benefits, or operational aspects to better suit the needs of both the employer and plan participants.

 

Examples of Plan Amendments:

 

  • Contribution Structure Modification: An employer may choose to implement a plan amendment to change the contribution structure of the 401(k) plan. For instance, they might decide to increase the employer match percentage or alter the employee contribution limits.

  • Vesting Schedule Adjustment: In certain cases, an employer might choose to amend the vesting schedule of the 401(k) plan. This amendment could alter the timeline that determines when employees become fully entitled to employer contributions.

 

  • Investment Options Update: A plan amendment can also involve updating the investment options available within the 401(k) plan. Employers might add or remove investment choices to provide participants with a more diverse and suitable range of investment opportunities.

 

It is crucial for employers to communicate plan amendments effectively to all plan participants, ensuring transparency and understanding of the changes. Additionally, the employer must comply with all legal requirements and provide sufficient notice to employees about the upcoming amendments to maintain compliance with applicable laws and regulations.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.